Home » Topics » Disease categories and therapies » Dental

Dental
RSS

CollaGenex and Merck establish copromotion agreement for Vioxx

Sep. 27, 1999

HRT may slow periodontal disease progression

Aug. 31, 1999

Emdogain approved by FDA for minimally invasive dental surgery

Aug. 13, 1999

CollaGenex signs marketing agreement for Periostat in Canada

July 5, 1999

Study results published for Atridox periodontal therapy

June 25, 1999

First E.U. approval of Atridox for periodontal disease

April 28, 1999

U.K approval of Atrix's periodontal drug delayed

April 16, 1999

Study data on Periodontix's gingivitis treatment reported

March 23, 1999

Actinova enters collaboration for development of tooth decay treatment

Jan. 22, 1999

Pharmacokinetic studies support safety of novel dental agent

Jan. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...